Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVITIUM PHARMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 27

FDA approve MESALAMINE

Comment Full text

HIKMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 26

FDA approve DEXMEDETOMIDINE HYDROCHLORIDE

Comment Full text

LEADING

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 23

FDA approve FROVATRIPTAN SUCCINATE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 17

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 21

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 26

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 18

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

RUBICON

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 21

FDA approve GUANFACINE HYDROCHLORIDE

Comment Full text

ENCUBE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 25

FDA approve NITROGLYCERIN

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 22

FDA approve NITAZOXANIDE

Comment Full text
  • Previous
  • 95
  • 96
  • 97
  • 98
  • 99
  • Next

Search

News categories

  • Technical Exchange News(9831)
  • Event(407)
  • SEC News(165213)
  • FDA Approval(9288)
  • Company Report(721)
  • Business News(110604)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin